Hana Must SPAC 2 (208370) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hana Must SPAC 2 (208370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩838.06 Million ≈ $567.94K USD) by net assets (₩63.95 Billion ≈ $43.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 208370 net asset quality score to measure how much of total assets are equity-financed.
Hana Must SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Hana Must SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hana Must SPAC 2 (208370) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Hana Must SPAC 2 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hana Must SPAC 2 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Makina Takim Endustrisi AS
IS:MAKTK
|
-0.038x |
|
Frasers Group PLC
LSE:FRAS
|
0.058x |
|
Woori SPAC 3
KQ:198440
|
0.050x |
|
Surapon Foods Public Company Limited
BK:SSF
|
0.082x |
|
BANXA HOLDINGS INC.
F:AC00
|
N/A |
|
Arianne Phosphate Inc
V:DAN
|
-0.019x |
|
Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA
F:MUT3
|
0.033x |
|
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ:MSSA
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Hana Must SPAC 2 (2015–2024)
The table below shows the annual cash flow conversion efficiency of Hana Must SPAC 2 from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Hana Must SPAC 2.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩63.80 Billion ≈ $43.24 Million |
₩4.50 Billion ≈ $3.05 Million |
0.071x | +22.09% |
| 2023-12-31 | ₩60.10 Billion ≈ $40.73 Million |
₩3.47 Billion ≈ $2.35 Million |
0.058x | +3640.27% |
| 2022-12-31 | ₩32.89 Billion ≈ $22.29 Million |
₩50.81 Million ≈ $34.43K |
0.002x | -98.52% |
| 2021-12-31 | ₩28.06 Billion ≈ $19.02 Million |
₩2.93 Billion ≈ $1.98 Million |
0.104x | -38.53% |
| 2020-12-31 | ₩24.89 Billion ≈ $16.87 Million |
₩4.23 Billion ≈ $2.86 Million |
0.170x | +11.18% |
| 2019-12-31 | ₩24.14 Billion ≈ $16.36 Million |
₩3.69 Billion ≈ $2.50 Million |
0.153x | +132.33% |
| 2018-12-31 | ₩14.60 Billion ≈ $9.90 Million |
₩-6.90 Billion ≈ $-4.67 Million |
-0.472x | -205.32% |
| 2017-12-31 | ₩27.81 Billion ≈ $18.85 Million |
₩-4.30 Billion ≈ $-2.92 Million |
-0.155x | +33.13% |
| 2016-12-31 | ₩26.92 Billion ≈ $18.24 Million |
₩-6.23 Billion ≈ $-4.22 Million |
-0.231x | -2788.35% |
| 2015-12-31 | ₩19.09 Billion ≈ $12.94 Million |
₩164.29 Million ≈ $111.33K |
0.009x | -- |
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more